Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Pipette Calibrators Market by Type (Devices, Software), Channel Type, Method (Gravimetry, Photometry), Application (Research (Drug Discovery), Clinical Diagnostics), End User (Pharmaceutical & Biotechnology), & Region - Global Forecast to 2029
... projected to reach USD 391 million by 2029 from USD 286 million in 2024, at a CAGR of 6.5% during the forecast period. The growth of this market is majorly driven by rise in automation ... Read More
-
Complicated Urinary Tract Infections Market Insight, Epidemiology And Market Forecast - 2034
... be further sub-divided into B cells, T cells and NK cells. Lymphomas are broadly divided into two major categories: Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). When NHL begins in the skin (not in another ... Read More
-
Acute Lymphocytic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032
... the market size of ALL in the 7MM was approximately USD 1,100 million, which is further expected to increase by 2032. In the 7MM, the US accounted for the largest market size in 2021, with ... Read More
-
Global Anemia Therapeutics Market Growth (Status and Outlook) 2024-2030
... market, the Anemia Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Anemia Therapeutics ... Read More
-
Epilepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies Analysis
... Globally, health systems struggle to provide critical medical offerings and ensure access to remedies for chronic conditions like epilepsy. Characterized by recurrent seizures, epilepsy entails unexpected, transient modifications in brain function, leading to convulsions, loss ... Read More
-
Global Neurological Disorder Drugs Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Neurological Disorder Drugs is forecast to a readjusted size of US$ 3513.2 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential ... Read More
-
2024 Global Forecast for Medical Membranes Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology And Market Forecast - 2034
... type of autoimmune hemolytic anemia, comprising nearly 70–80% of all adult cases and 50% of pediatric cases. wAIHA can develop at any age, but the median age of onset is 52 years. The primary and ... Read More
-
Down Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
... of peripheral number injuries of upper extremities in the 7MM were ~2.9 million and of lower extremities were ~1.1 million. Surgical treatment aims to repair the damaged nerve, maximize the number of axons that regenerate ... Read More
-
Parainfluenza Virus Infection Market Insight, Epidemiology And Market Forecast - 2034
... the lungs. This syndrome can arise from various acute injuries, leading to significant morbidity and mortality rates among affected individuals. In 2023, the market size of Acute Respiratory Distress Syndrome (ARDS) was highest in the ... Read More
-
Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology And Market Forecast - 2034
... primary cause of morbidity and presents many difficulties and treatment challenges. Malignant ascite is a sign of peritoneal carcinomatosis, the presence of malignant cells in the peritoneal cavity. Malignant ascites, characterized by the abnormal accumulation ... Read More
-
Peripheral Nerve Injuries Market Insight, Epidemiology And Market Forecast - 2034
... significant CAGR during the forecast period. Among the 7MM, the United States accounted for the largest market size of ACS, i.e., approximately 80% of the overall market in 2023. ACS are associated with a broad ... Read More
-
Global Celiac Disease Drugs Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Celiac Disease Drugs is forecast to a readjusted size of US$ 1596 million by 2030 with a CAGR of 15.4% during review period. The research report highlights the growth potential ... Read More
-
Rare Disease Pipeline Analysis Landscape in 2023
... key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot to prioritize these trends within your sector. Scope This 29-page ... Read More
-
Global Label-Free Drug Discovery Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Label-Free Drug Discovery is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Mice Model Market by Model Types (Inbred, Outbred, Hybrid), Services (Breeding, Rederivation), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology, Immunology), Application (Research, Drug Discovery) - Global Forecast to 2029
... to reach USD 2.2 billion by 2029 from an estimated USD 1.5 billion in 2024, at a CAGR of 8.1% during the forecast period. The growth of this market can be attributed to the research ... Read More
-
Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Research Report 2024
... break down and die. The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to ... Read More
-
Sickle Cell Anemia Therapeutics Industry Research Report 2024
... The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS). Highlights The global Sickle Cell Anemia Therapeutics market is ... Read More
-
Preclinical CRO Market Share, Size, Trends, Industry Analysis Report, By Service Type (Toxicology Testing, Bioanalysis & DMPK studies, Chemistry, Compound Management, Others); By Mode; By End-User; By Region; Segment Forecast, 2024 - 2032
... preclinical CRO market size is expected to reach USD 11.90 billion by 2032, according to a new study by Polaris Market Research. The report “Preclinical CRO Market Share, Size, Trends, Industry Analysis Report, By Service ... Read More
-
Orphan Drugs Global Market Report 2024
... Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Sales Covering: Pfizer Inc.; Johnson & Johnson Services Inc.; F Hoffmann-La Roche Ltd.; Farbenfabriken Bayer AG; Novartis AG Orphan Drugs Global Market Report 2024 from The Business Research ... Read More
-
Gout (Chronic Refractory)
... Every MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable ... Read More
-
Organ-On-Chip Market by Organ Type (Liver, Kidney, Intestine, Lung, Heart), Products (Instruments, Consumable, Software), Services (Standard, Custom), Model Type, Application (Toxicology, Drug Discovery, Stem Cell), Purpose - Global Forecast to 2029
... expected to reach USD 631,073 thousand by 2029 from USD 123,285 thousand in 2024, at a CAGR of 38.6% during the forecast period. The key factors driving the growth of the organ-on-chip market include growing ... Read More
-
Artificial Intelligence (AI) In Drug Discovery Global Market Report 2024
... Metabolic Disease; Cardiovascular Disease; Oncology; Neurodegenerative Diseases; Anti-Infective Diseases; Respiratory Diseases 4) By End User: Pharmaceutical Companies; Biopharmaceutical Companies; Academic And Research Institutes Covering: IBM Corporation; Microsoft Corporation; NVIDIA Corporation; Exscientia; Alphabet Artificial Intelligence (AI) ... Read More
-
Sarcopenia Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 4.48% during the forecast period (2024-2029). Factors such as the rise in the geriatric population and the increase in malnutrition, coupled with vitamin deficiency globally, are expected ... Read More
-
Global Crohn’s Disease Therapeutics Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Crohn’s Disease Therapeutics is forecast to a readjusted size of US$ 3593 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential ... Read More
Research Assistance
